US 10208089
Modulation of complement activity
granted A61KA61K38/00A61K47/64
Quick answer
US patent 10208089 (Modulation of complement activity) held by RA PHARMACEUTICALS, INC. expires Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- RA PHARMACEUTICALS, INC.
- Grant date
- Tue Feb 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61K47/64, A61K47/645, A61P